Generally, it can be concluded that the investigated PSMA–ADCs have failed, so far, in delivering the cytotoxic payload specifically to the tumor, due to their instability in blood circulation and the subsequent premature drug release. The gene discussed is FOLH1; the disease is neoplasm.